AI Act: How To Preserve EU’s Industrial Competitiveness Through Proportionate Regulation

19 Jun 2024

The AI medtech revolution could be a “huge, missed opportunity” for the EU without an effective and efficient regulatory infrastructure. Answers are needed fast, MedTech Europe’s Oliver Bisazza said during a recent interview.

Chess pieces in different lanes, symbolizing a race, — The EU Does Not Want To Fall Behind When It Comes To AI In Medtech

Some of the most exciting medtech innovations are in the digital space. If they come to Europe later than they should because of uncertainty about the AI Act, then that is going to be a “huge, missed opportunity” for patients and healthcare systems in Europe.

That is the view of Oliver Bisazza, CEO of MedTech Europe, during an interview with Medtech Insight during the first...